Deng‐Yn Lin
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Hepatitis C virus research
-
- Cancer Mechanisms and Therapy
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Hepatitis C virus research 3
- Liver physiology and pathology 2
-
- Hepatitis B Virus Studies 4
- Liver Disease Diagnosis and Treatment 3
- Co-authors
- Ann‐Lii Cheng (2 shared papers)Masao Omata (1 shared paper)Masatoshi Kudo (1 shared paper)Guido Poggi (1 shared paper)Hyun Cheol Chung (1 shared paper)Silvana Lanzalone (1 shared paper)Éric Raymond (1 shared paper)Joong‐Won Park (1 shared paper)
- Journals
- Journal of Hepatology (2 papers)Journal of Clinical Oncology (1 paper)Journal of Clinical Gastroenterology (1 paper)Acta Cytologica (1 paper)Liver Cancer (1 paper)
- Partner nations
- TaiwanSouth KoreaGermany
In The Last Decade
Deng‐Yn Lin
9 papers receiving 937 citations
Deng‐Yn Lin's Hit Papers
Peers
Comparison fields: 5 of 67
- Hepatology 670
- Pathology and Forensic Medicine 284
- Cancer Research 170
- Epidemiology 278
- Oncology 181
Countries citing papers authored by Deng‐Yn Lin
This map shows the geographic impact of Deng‐Yn Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deng‐Yn Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deng‐Yn Lin more than expected).
Fields of papers citing papers by Deng‐Yn Lin
This network shows the impact of papers produced by Deng‐Yn Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deng‐Yn Lin. The network helps show where Deng‐Yn Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Deng‐Yn Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial Hit paper breakdown → | 2013 | 586 |
| 2 | 2009 | 121 | |
| 3 | 2011 | 110 | |
| 4 | 1988 | 54 | |
| 5 | 1996 | 33 | |
| 6 | 2018 | 21 | |
| 7 | 1991 | 11 | |
| 8 | 2013 | 9 | |
| 9 | 2002 | 8 |
About Deng‐Yn Lin
Deng‐Yn Lin is a scholar working on Hepatology, Epidemiology, Surgery, Cell Biology and Infectious Diseases, having authored 9 papers that have together received 953 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Hepatitis B Virus Studies (4 papers), Hepatitis C virus research (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Liver physiology and pathology (2 papers), Cancer Mechanisms and Therapy (1 paper), Multiple Myeloma Research and Treatments (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Hepatology (670 citations), Pathology and Forensic Medicine (284 citations), Cancer Research (170 citations), Epidemiology (278 citations) and Oncology (181 citations). Deng‐Yn Lin has collaborated with scholars based in Taiwan, South Korea and Germany. Frequent co-authors include Ann‐Lii Cheng, Masao Omata, Masatoshi Kudo, Guido Poggi, Hyun Cheol Chung, Silvana Lanzalone, Éric Raymond, Joong‐Won Park, Yoon‐Koo Kang and María José Lechuga. Their work appears in journals such as Journal of Hepatology, Journal of Clinical Oncology, Journal of Clinical Gastroenterology, Acta Cytologica and Liver Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.